Complex formulary structures, high initial pricing, entrenched market advantages favoring established brands, and hesitancy among prescribers and patients have slowed adoption, leaving billions in savings untapped.

Specialty drugs now command a significant share of drug spend, hitting $301 billion in 2021. It's critical for benefits advisors to understand these trends and implement strategies to manage costs and risks. Learn how to protect your financial interests while ensuring essential medication access for your members.